{
    "nctId": "NCT03661892",
    "briefTitle": "Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets",
    "officialTitle": "Title A Pilot Trial to Evaluate Syndros in Decreasing Opioid Requirement in Patients With Bone Metastases From Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Bone Metastases, Breast Cancer, Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 14,
    "primaryOutcomeMeasure": "Need for opiate pain medication",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Be capable of understanding the investigational nature of the study and all pertinent aspects of the study\n2. Be capable of signing and providing written consent in accordance with institutional and federal guidelines\n3. Have metastatic breast cancer with bone metastases\n4. Be willing and able to comply with scheduled visits, treatment plan, and follow up with research staff\n5. Age \u2265 21 years\n6. Must be on opioid therapy for bone pain for at least 4 weeks\n\nExclusion Criteria:\n\n1. Have a known sensitivity to dronabinol or alcohol\n2. Have a history of hypersensitivity reaction to alcohol\n3. Using medical marijuana currently\n4. Using Syndros for nausea or appetite stimulant\n5. Receiving or have received disulfiram- or metronidazole- containing products within past 14 days\n6. Are currently pregnant or are of child-bearing age and refuse to use adequate contraception\n7. Have a history of psychiatric illness\n8. Have a history of seizure disorders",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}